Jelmer Raaijmakers (J Raaijmakers)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Molecularly Imprinted

Extracorporeal Membrane Oxygenation

Pulmonary Tuberculosis

Clinical Practice

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse, Elin M Svensson, Khalid Asouit, Erik van den Hombergh, Lindsey Te Brake, Ralf Stemkens, Heiman F L Wertheim, Wouter Hoefsloot, Jakko van Ingen
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial agents and chemotherapy 68 (3) (2024)
J W A Mouton, Jelmer Raaijmakers, M Botterblom, M Toonen, R Ter Heine, R L Smeets, Roger J M Brüggemann, L Te Brake, Nynke G L Jager
Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum. The Journal of antimicrobial chemotherapy (2023)
Jodie Anne Schildkraut, Jelmer Raaijmakers, Rob Aarnoutse, Wouter Hoefsloot, Heiman F L Wertheim, Jakko van Ingen
The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease. Antimicrobial agents and chemotherapy (2023)
Jelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot, Jakko van Ingen
The role of amikacin in the treatment of nontuberculous mycobacterial disease. Expert opinion on pharmacotherapy 22 (15) (2021)